Clinical Trial Update: A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) [Phase 1]

View source ↗

Summary

The Phase 1 study MK-0859-011 in patients with primary hypercholesterolemia or mixed hyperlipidemia has completed; this update confirms the completion of the ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• MK-0859

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia, Hyperlipidemia | Phase 1 | Status: COMPLETED